JOHN SHEPARD: Open Payments
NPI 1952958548 · KNIGHTDALE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,225 in 35 payments from 17 companies in 2025. Trend: 2023 $73 · 2024 $120 · 2025 $1,225
Food & beverage: $1,126Education: $99
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $238 |
| Organon LLC | 4 | $188 |
| Regeneron Healthcare Solutions, Inc. | 4 | $179 |
| LEO Pharma Inc. | 3 | $101 |
| ABBVIE INC. | 4 | $95 |
| Amgen Inc. | 4 | $83 |
| Arcutis Biotherapeutics, Inc. | 1 | $78 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $39 |
| UCB, Inc. | 1 | $30 |
Products named: DUPIXENT, ADBRY, Zoryve, RINVOQ, KRYSTEXXA, Xeomin, Sotyktu, Bimzelx.
Industry payments across NC — which companies pay providers there.
